SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Investors are expressing frustration over a sharp sell-off in Oracle shares despite a strong earnings report, with many pointing to options expiration and institutional selling as the primary drivers of the volatility. Debate continues regarding the company's debt levels and capital expenditures, while some traders view the price dip as an attractive entry point for the long term.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

The stock declined as a surge of negative sentiment and high volume on social media fueled concerns over a third-party statistical model that revised the odds of success for the company's ongoing Phase 3 trial. Traders remain divided, with many dismissing the move as a coordinated short attack and temporary volatility driven by stop-loss harvesting rather than any fundamental change in the clinical outlook.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin shares are seeing significant volatility as traders debate whether the stock is undergoing institutional accumulation or being systematically manipulated by market makers, leading to frequent intraday reversals despite strong fundamentals. While many investors remain bullish due to the company's high profit margins and potential for growth in the e-commerce advertising space, the stock's inability to hold gains during broader market rallies has sparked significant frustration and debate over the impact of short-term algorithmic trading and analyst price target revisions.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin is trending as investors discuss ongoing infrastructure developments and speculation surrounding potential institutional partnerships and the acquisition of Chain. While some traders express optimism regarding the project's long-term utility and neobank integration, others remain highly skeptical, frequently labeling the recent price action as a pump-and-dump scheme.

the cat on Base  community-run home for $BASECAT

Basecat

Basecat is experiencing significant price volatility following its recent listing on Coinbase, with traders debating whether the current decline represents a typical "pump and dump" cycle or a buying opportunity. While some community members view the pullback as a chance to accumulate, others express skepticism about the token's long-term sustainability as a meme asset.

Alliance Entertainment Holding Corp. engages in the distribution of music, movies, and consumer electronics. It distributes its physical media, entertainment products, hardware, and accessories through an established multi-channel strategy. The company was founded in 1990 and is headquartered in Plantation, FL.

Alliance Entertainment Holding Corporation - Ordinary Shares - Class A

AENT is experiencing high volatility as traders debate the impact of the company's low-float structure and recent earnings results, with many expressing frustration over persistent downward price pressure and the influence of short sellers. Investors remain divided, with some highlighting the company's profitable operations and pivot to collectibles as reasons for long-term optimism, while others remain skeptical due to the lack of trading volume and recent governance developments.

NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by José N. Reyes in 2007 and is headquartered in Corvallis, OR.

NuScale Power Corporation - Ordinary Shares - Class A

NuScale Power Corp

NuScale Power is trading lower following a downgrade by UBS, which cited concerns over a prolonged construction timeline and limited firm customer commitments. The community remains divided, with many retail traders dismissing the downgrade as an attempt to suppress the price, while others argue that the company's long-term thesis hinges on its ability to convert project discussions into binding commercial agreements.

Amplify Commodity Trust - Breakwave Tanker Shipping ETF

Breakwave Tanker Shipping ETF

The Breakwave Tanker Shipping ETF is trending due to surging tanker freight rates driven by geopolitical instability in the Strait of Hormuz and Red Sea, which has significantly increased transport costs and shipping distances. The community is actively debating the fund's extreme volatility and long-term viability, with many traders viewing it as a high-stakes play on oil shipping disruptions while others express skepticism about its sustainability.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group shares are trending as traders debate the stock's recent volatility following strong quarterly earnings, with many attributing the downward pressure to institutional manipulation and sector-wide weakness while others view it as a long-term value opportunity. Discussion is frequently focused on the stock's defensive role in portfolios, upcoming ex-dividend dates, and speculative reactions to regulatory developments.

RTX Corp. is an aerospace and defense company, which engages in the provision of aerospace and defense systems and services for commercial, military, and government customers. It operates through the following segments: Collins Aerospace Systems (Collins), Pratt and Whitney, Raytheon Intelligence and Space (RIS), and Raytheon Missiles and Defense (RMD). The Collins segment manufactures and sells aero structures, avionics, interiors, mechanical systems, mission systems, and power controls. The Pratt and Whitney segment includes the design and manufacture of aircraft engines and auxiliary power systems for commercial, military, and business aircraft. The RIS segment is involved in the development of sensors, training, and cyber and software solutions. The RMD segment offers end-to-end solutions to detect, track, and engage threats. The company was founded in 1922 and is headquartered in Arlington, VA.

RTX Corp

Raytheon Technologies Corporation

RTX is trending as traders react to a pullback in defense stocks despite a strong financial performance and a record backlog. Market sentiment remains divided, with some investors viewing the price decline as a buying opportunity given the company's role in global munitions replenishment, while others express frustration over the recent downward momentum.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$SLS $MRNA $ABBV added Venetoclax to Onureg  for First Remission Patients in the VIALE-M Trial. 
 
Onureg / Oral Aza MOS is 24.7 months  
ADDING VEN did not increase Survival 
 
Gps Phase 3 MOS - in the ONGOING P3 will come in 34/36 Months ... 
Gps Phase 3 CR2 MOS - in the ONGOING P3 will come in 34/36 Months ... 
Longer MOS in CR2 than SOC in CR1... 
 
GPs Phase 2 MOS in CR1 was 67.6 Months 
GPS Phase 2 MOS in CR2 was 21 months  
- an older, Less Healthy all MRD+ setting, with less Gps Dosing.

Christy Morgan

5,500% ROI this quarter

Jim Halpin

$SLS With all the FUD...  
Yes Best Available Treatment BAT for Control Patients - Aza+VEN - FAILED 3 Large Phase 3 Trials conducted by $ABBV  
 
VIALE-T FAILED for Post Transplant Maintenance 
 
VIALE-M Failed for AML FIRST REMISSION Maintenance 
 
Aza+VEN is Failing for AML SECOND Remission Maintenance too. 
 
its even more toxic and ineffective in the Later Stage. 
 
They TRIED 8 Different Oral/IV/subq dosing regimes... all failed.

StockTwits Web

Abbvie Inc

$SLS $ABBV  
Onureg / Oral Aza MOS is 24.7 months   
 
 
ADDING VEN did not increase Survival

$SLS The facts are the Facts  
 
Always be buying when the Shorts are  A Lying. 
 
W.BUFFET 1992

Moderna Inc

 added Venetoclax to Onureg  for First Remission Patients in the VIALE-M Trial. 
 
Onureg / Oral Aza MOS is 24.7 months  
ADDING VEN did not increase Survival 
 
Gps Phase 3 MOS - in the ONGOING P3 will come in 34/36 Months ... 
Gps Phase 3 CR2 MOS - in the ONGOING P3 will come in 34/36 Months ... 
Longer MOS in CR2 than SOC in CR1... 
 
GPs Phase 2 MOS in CR1 was 67.6 Months 
GPS Phase 2 MOS in CR2 was 21 months  
- an older, Less Healthy all MRD+ setting, with less Gps Dosing.